Myriad Genetics (MYGN) PT Lowered to $7 at Morgan Stanley
Tweet
Share
E-mailGet Alerts MYGN Hot Sheet
Price: $3.05 +0.66%
Rating Summary:
7 Buy, 19 Hold, 4 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 12 | Down: 23 | New: 22
Rating Summary:
7 Buy, 19 Hold, 4 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 12 | Down: 23 | New: 22
Join SI Premium – FREE
Morgan Stanley analyst Tejas Savant lowered the price target on Myriad Genetics (NASDAQ: MYGN) to $7.00 (from $16.00) while maintaining a Equalweight rating.
You May Also Be Interested In
- Freedom Broker Upgrades PrimeEnergy Resource (PNRG) to Hold
- JD Logistics Inc (2618:HK) (JDLGF) PT Lowered to HK$18 at Nomura/Instinet
- Candel Therapeutics Inc. (CADL) PT Raised to $15 at Freedom Broker
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
